Macrogenics (MGNX) Return on Capital Employed Growth (5y) (2018 - 2026)
Macrogenics (MGNX) Return on Capital Employed Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Macrogenics | 249.99 Mn | 183.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -634.00 |
| Dec 31, 2025 | 721.00 |
| Sep 30, 2025 | 252.00 |
| Jun 30, 2025 | 2,776.00 |
| Mar 31, 2025 | 1,720.00 |
| Dec 31, 2024 | 850.00 |
| Sep 30, 2024 | -358.00 |
| Jun 30, 2024 | -6,727.00 |
| Mar 31, 2024 | -3,194.00 |
| Dec 31, 2023 | -362.00 |
| Sep 30, 2023 | -3,177.00 |
| Jun 30, 2023 | -2,240.00 |
| Mar 31, 2023 | -2,361.00 |
| Dec 31, 2022 | -5,556.00 |
| Sep 30, 2022 | -5,047.00 |
| Jun 30, 2022 | -5,251.00 |
| Mar 31, 2022 | -6,696.00 |
| Dec 31, 2021 | -5,001.00 |
| Sep 30, 2021 | -2,707.00 |
| Jun 30, 2021 | -2,546.00 |